<?xml version="1.0" encoding="UTF-8"?>
<p>The compound GB-2a significantly inhibited the melanin content without reducing cell viability, suggesting its great potential for medical use as a hypopigmentation agent, for cosmetic and clinical applications related to skin clearing [
 <xref rid="B64-molecules-25-04513" ref-type="bibr">64</xref>]. The compound fukugetin (or morelloflavone) showed an anti-inflammatory activity in mouse paw edema induced by carrageenin at a concentration of 300 mg/kg, rendering the plant a potential target for the development of new compounds to be explored as alternatives to drugs with anti-inflammatory activity that are already in use [
 <xref rid="B65-molecules-25-04513" ref-type="bibr">65</xref>].
</p>
